Taranabant tackles a weighty problem

Gespeichert in:

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2007

Schlagwörter:	Placebo Sibutramine Respiratory Quotient Inverse Agonist Active Therapy

Anmerkung:	© Adis International Ltd 2007

Übergeordnetes Werk:	Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 1607(2007), 1 vom: Sept., Seite 15-15
Übergeordnetes Werk:	volume:1607 ; year:2007 ; number:1 ; month:09 ; pages:15-15

Links:	Volltext

DOI / URN:	10.2165/00128413-200716070-00023

Katalog-ID:	SPR035299495

Internformat


LEADER	01000caa a22002652 4500
001	SPR035299495
003	DE-627
005	20230519112537.0
007	cr uuu---uuuuu
008	201007s2007 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.2165/00128413-200716070-00023 \|2 doi
035			\|a (DE-627)SPR035299495
035			\|a (SPR)00128413-200716070-00023-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a Taranabant tackles a weighty problem
264		1	\|c 2007
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Adis International Ltd 2007
650		4	\|a Placebo \|7 (dpeaa)DE-He213
650		4	\|a Sibutramine \|7 (dpeaa)DE-He213
650		4	\|a Respiratory Quotient \|7 (dpeaa)DE-He213
650		4	\|a Inverse Agonist \|7 (dpeaa)DE-He213
650		4	\|a Active Therapy \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t Inpharma weekly \|d Auckland : ADIS internat., 1975 \|g 1607(2007), 1 vom: Sept., Seite 15-15 \|w (DE-627)373977859 \|w (DE-600)2127607-9 \|x 2230-6056 \|7 nnns
773	1	8	\|g volume:1607 \|g year:2007 \|g number:1 \|g month:09 \|g pages:15-15
856	4	0	\|u https://dx.doi.org/10.2165/00128413-200716070-00023 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
912			\|a GBV_ILN_206
912			\|a GBV_ILN_2005
912			\|a GBV_ILN_2009
912			\|a GBV_ILN_2011
912			\|a GBV_ILN_2055
912			\|a GBV_ILN_2111
912			\|a GBV_ILN_4305
951			\|a AR
952			\|d 1607 \|j 2007 \|e 1 \|c 09 \|h 15-15

Indexfelder

matchkey_str	article:22306056:2007----::aaaatakeaegt
hierarchy_sort_str	2007
publishDate	2007
allfields	10.2165/00128413-200716070-00023 doi (DE-627)SPR035299495 (SPR)00128413-200716070-00023-e DE-627 ger DE-627 rakwb eng Taranabant tackles a weighty problem 2007 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2007 Placebo (dpeaa)DE-He213 Sibutramine (dpeaa)DE-He213 Respiratory Quotient (dpeaa)DE-He213 Inverse Agonist (dpeaa)DE-He213 Active Therapy (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1607(2007), 1 vom: Sept., Seite 15-15 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1607 year:2007 number:1 month:09 pages:15-15 https://dx.doi.org/10.2165/00128413-200716070-00023 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1607 2007 1 09 15-15
spelling	10.2165/00128413-200716070-00023 doi (DE-627)SPR035299495 (SPR)00128413-200716070-00023-e DE-627 ger DE-627 rakwb eng Taranabant tackles a weighty problem 2007 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2007 Placebo (dpeaa)DE-He213 Sibutramine (dpeaa)DE-He213 Respiratory Quotient (dpeaa)DE-He213 Inverse Agonist (dpeaa)DE-He213 Active Therapy (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1607(2007), 1 vom: Sept., Seite 15-15 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1607 year:2007 number:1 month:09 pages:15-15 https://dx.doi.org/10.2165/00128413-200716070-00023 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1607 2007 1 09 15-15
allfields_unstemmed	10.2165/00128413-200716070-00023 doi (DE-627)SPR035299495 (SPR)00128413-200716070-00023-e DE-627 ger DE-627 rakwb eng Taranabant tackles a weighty problem 2007 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2007 Placebo (dpeaa)DE-He213 Sibutramine (dpeaa)DE-He213 Respiratory Quotient (dpeaa)DE-He213 Inverse Agonist (dpeaa)DE-He213 Active Therapy (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1607(2007), 1 vom: Sept., Seite 15-15 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1607 year:2007 number:1 month:09 pages:15-15 https://dx.doi.org/10.2165/00128413-200716070-00023 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1607 2007 1 09 15-15
allfieldsGer	10.2165/00128413-200716070-00023 doi (DE-627)SPR035299495 (SPR)00128413-200716070-00023-e DE-627 ger DE-627 rakwb eng Taranabant tackles a weighty problem 2007 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2007 Placebo (dpeaa)DE-He213 Sibutramine (dpeaa)DE-He213 Respiratory Quotient (dpeaa)DE-He213 Inverse Agonist (dpeaa)DE-He213 Active Therapy (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1607(2007), 1 vom: Sept., Seite 15-15 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1607 year:2007 number:1 month:09 pages:15-15 https://dx.doi.org/10.2165/00128413-200716070-00023 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1607 2007 1 09 15-15
allfieldsSound	10.2165/00128413-200716070-00023 doi (DE-627)SPR035299495 (SPR)00128413-200716070-00023-e DE-627 ger DE-627 rakwb eng Taranabant tackles a weighty problem 2007 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2007 Placebo (dpeaa)DE-He213 Sibutramine (dpeaa)DE-He213 Respiratory Quotient (dpeaa)DE-He213 Inverse Agonist (dpeaa)DE-He213 Active Therapy (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1607(2007), 1 vom: Sept., Seite 15-15 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1607 year:2007 number:1 month:09 pages:15-15 https://dx.doi.org/10.2165/00128413-200716070-00023 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1607 2007 1 09 15-15
language	English
source	Enthalten in Inpharma weekly 1607(2007), 1 vom: Sept., Seite 15-15 volume:1607 year:2007 number:1 month:09 pages:15-15
sourceStr	Enthalten in Inpharma weekly 1607(2007), 1 vom: Sept., Seite 15-15 volume:1607 year:2007 number:1 month:09 pages:15-15
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Placebo Sibutramine Respiratory Quotient Inverse Agonist Active Therapy
isfreeaccess_bool	false
container_title	Inpharma weekly
publishDateDaySort_date	2007-09-01T00:00:00Z
hierarchy_top_id	373977859
id	SPR035299495
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035299495</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519112537.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2007 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200716070-00023</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035299495</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200716070-00023-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Taranabant tackles a weighty problem</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2007</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2007</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Placebo</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Sibutramine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Respiratory Quotient</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Inverse Agonist</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Active Therapy</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1607(2007), 1 vom: Sept., Seite 15-15</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1607</subfield><subfield code="g">year:2007</subfield><subfield code="g">number:1</subfield><subfield code="g">month:09</subfield><subfield code="g">pages:15-15</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200716070-00023</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1607</subfield><subfield code="j">2007</subfield><subfield code="e">1</subfield><subfield code="c">09</subfield><subfield code="h">15-15</subfield></datafield></record></collection>
ppnlink_with_tag_str_mv	@@773@@(DE-627)373977859
format	electronic Article
delete_txt_mv	keep
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2230-6056
topic_title	Taranabant tackles a weighty problem Placebo (dpeaa)DE-He213 Sibutramine (dpeaa)DE-He213 Respiratory Quotient (dpeaa)DE-He213 Inverse Agonist (dpeaa)DE-He213 Active Therapy (dpeaa)DE-He213
topic	misc Placebo misc Sibutramine misc Respiratory Quotient misc Inverse Agonist misc Active Therapy
spellingShingle	misc Placebo misc Sibutramine misc Respiratory Quotient misc Inverse Agonist misc Active Therapy Taranabant tackles a weighty problem
topic_unstemmed	misc Placebo misc Sibutramine misc Respiratory Quotient misc Inverse Agonist misc Active Therapy
topic_browse	misc Placebo misc Sibutramine misc Respiratory Quotient misc Inverse Agonist misc Active Therapy
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Inpharma weekly
hierarchy_parent_id	373977859
hierarchy_top_title	Inpharma weekly
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)373977859 (DE-600)2127607-9
title	Taranabant tackles a weighty problem
ctrlnum	(DE-627)SPR035299495 (SPR)00128413-200716070-00023-e
title_full	Taranabant tackles a weighty problem
journal	Inpharma weekly
journalStr	Inpharma weekly
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	2007
contenttype_str_mv	txt
container_start_page	15
container_volume	1607
format_se	Elektronische Aufsätze
doi_str_mv	10.2165/00128413-200716070-00023
title_sort	taranabant tackles a weighty problem
title_auth	Taranabant tackles a weighty problem
abstract	© Adis International Ltd 2007
abstractGer	© Adis International Ltd 2007
abstract_unstemmed	© Adis International Ltd 2007
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305
container_issue	1
title_short	Taranabant tackles a weighty problem
url	https://dx.doi.org/10.2165/00128413-200716070-00023
remote_bool	true
ppnlink	373977859
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.2165/00128413-200716070-00023
up_date	2024-07-03T14:05:22.313Z
_version_	1803566996328022016
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035299495</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519112537.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2007 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200716070-00023</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035299495</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200716070-00023-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Taranabant tackles a weighty problem</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2007</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2007</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Placebo</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Sibutramine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Respiratory Quotient</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Inverse Agonist</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Active Therapy</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1607(2007), 1 vom: Sept., Seite 15-15</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1607</subfield><subfield code="g">year:2007</subfield><subfield code="g">number:1</subfield><subfield code="g">month:09</subfield><subfield code="g">pages:15-15</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200716070-00023</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1607</subfield><subfield code="j">2007</subfield><subfield code="e">1</subfield><subfield code="c">09</subfield><subfield code="h">15-15</subfield></datafield></record></collection>
score	7.401016

Nicht das Richtige dabei?

Schreiben Sie uns!

Taranabant tackles a weighty problem

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?